Accellix Revenue and Competitors
Estimated Revenue & Valuation
- Accellix's estimated annual revenue is currently $13.8M per year.
- Accellix's estimated revenue per employee is $155,000
- Accellix's total funding is $19.5M.
Employee Data
- Accellix has 89 Employees.
- Accellix grew their employee count by 22% last year.
Accellix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Accellix?
Accellix aims to enable cell and gene therapy companies to meet their key product QC requirements by providing fast and actionable multi-parameter results using the Accellix instrument and a room temperature stable cartridge. Accellix will continue to identify markets where its platform and assay migration expertise can be best combined to create meaningful opportunities.
keywords:N/A
$19.5M
Total Funding
89
Number of Employees
$13.8M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accellix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | QMS Coordinator | Reveal Email/Phone |
3 | Chairman and CEO | Reveal Email/Phone |
4 | Sales Operations and Customer Support Manager | Reveal Email/Phone |
5 | Director, Consumables Manufacturing/Quality Assurance | Reveal Email/Phone |
6 | Sr. Sales Manager | Reveal Email/Phone |
7 | Director Sales, North America | Reveal Email/Phone |
8 | Associate Director Global Sales | Biotechnology | Silicon Valley | Reveal Email/Phone |
9 | Field Application Manager | Reveal Email/Phone |
10 | Field Application Scientist | Reveal Email/Phone |
Accellix News
Accellix, a San Jose, CA and Jerusalem, Israel-based cell therapy QC company, raised $9.5M in Series D funding. The round was led by bioMérieux, with participation from existing major investors, who have also agreed to convert their pre-existing convertible note in the amount of $8.5m. This bro ...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.8M | 89 | 6% | N/A |
#2 | $7.5M | 89 | 3% | N/A |
#3 | $12.9M | 89 | 6% | N/A |
#4 | $18.7M | 89 | 0% | N/A |
#5 | $25.8M | 89 | 3% | N/A |